Koyfin Home > Directory > Health Care > Amphastar Pharma > Cost of Goods Sold

Amphastar Pharma Cost of Goods Sold Chart (AMPH)

Amphastar Pharma annual/quarterly Cost of Goods Sold from 2014 to 2018.
  • Amphastar Pharma Cost of Goods Sold for the quarter ending December 12, 2018 was $55m a 24.99% increase of 14m year over year
  • Amphastar Pharma Cost of Goods Sold for the last 12 months ending December 12, 2018 was $188m a 16.46% increase of 31m year over year
  • Amphastar Pharma Annual Cost of Goods Sold for 2018 was $188m a 20.41% increase of 38m from 2017
  • Amphastar Pharma Annual Cost of Goods Sold for 2017 was $149m a -1.07% decrease of -2m from 2016
  • Amphastar Pharma Annual Cost of Goods Sold for 2016 was $151m a -15.36% decrease of -23m from 2015
Other Income Statement Metrics:
  • Amphastar Pharma EBITDA for the quarter ending December 12, 2018 was $6m a 196.48% increase of 11m year over year
  • Amphastar Pharma Net Income for the quarter ending December 12, 2018 was $2m a 488.11% increase of 9m year over year
  • Amphastar Pharma Total Revenue for the quarter ending December 12, 2018 was $90m a 34.89% increase of 31m year over year
View Chart On Koyfin

Quarterly AMPH Cost of Goods Sold Data

12/2018$55m
09/2018$46m
06/2018$45m
03/2018$41m
12/2017$40m
09/2017$37m
06/2017$38m
03/2017$34m
12/2016$44m
09/2016$37m

Annual AMPH Cost of Goods Sold Data

2018$188m
2017$149m
2016$151m
2015$174m
2014$159m
2013$143m